BACKGROUND: Tamoxifen, a nonsteroidal estrogen agonist-antagonist, is used in the treatment of breast cancer. CASE: A postmenopausal woman, aged 73, while being treated with Tamoxifen, developed continuous growth of her myomatous uterus, became symptomatic and required surgery. CONCLUSION: Tamoxifen at a dose of 40 mg/d has been associated with endometrial carcinoma. The growth of myomas seen with Tamoxifen in this patient seems to be a result of its direct agonist properties.
|Original language||English (US)|
|Number of pages||2|
|Journal||Journal of Reproductive Medicine for the Obstetrician and Gynecologist|
|State||Published - 1996|
All Science Journal Classification (ASJC) codes
- Reproductive Medicine
- Obstetrics and Gynecology